Protection against poxviruses.
作者信息
Boulter E A
出版信息
Proc R Soc Med. 1969 Mar 3;62(3):295-7. doi: 10.1177/003591576906200349.
Abstract
摘要
相似文献
1
Protection against poxviruses.针对痘病毒的防护。
Proc R Soc Med. 1969 Mar 3;62(3):295-7. doi: 10.1177/003591576906200349.
2
Differences between extracellular and intracellular forms of poxvirus and their implications.痘病毒细胞外形式与细胞内形式的差异及其影响。
Prog Med Virol. 1973;16:86-108.
3
The nature of the immune state produced by inactivated vaccinia virus in rabbits.兔体内灭活痘苗病毒所产生免疫状态的性质。
Am J Epidemiol. 1971 Dec;94(6):612-20. doi: 10.1093/oxfordjournals.aje.a121360.
4
Studies on the standardization of smallpox vaccine. 3. An assay with a rabbit preliminarily immunized by passive immunization.天花疫苗标准化研究。3. 对经被动免疫初步免疫的兔子进行的测定。
Yokohama Med Bull. 1967 Oct;18(5):145-52.
5
Vaccinia necrosum and its relationship to impaired immunologic responsiveness.
Am J Med. 1972 Mar;52(3):411-20. doi: 10.1016/0002-9343(72)90031-9.
6
7
Highly attenuated smallpox vaccine protects rabbits and mice against pathogenic orthopoxvirus challenge.高度减毒的天花疫苗可保护兔和小鼠免受致病性正痘病毒的攻击。
Vaccine. 2006 Apr 24;24(17):3686-94. doi: 10.1016/j.vaccine.2005.03.029.
8
Immunization against smallpox.
Br Med Bull. 1969 May;25(2):131-5. doi: 10.1093/oxfordjournals.bmb.a070681.
9
Smallpox vaccination and patients with human immunodeficiency virus infection or acquired immunodeficiency syndrome.天花疫苗接种与人类免疫缺陷病毒感染或获得性免疫缺陷综合征患者
Clin Infect Dis. 2003 Feb 15;36(4):468-71. doi: 10.1086/368093. Epub 2003 Jan 30.
10
Controlling orthopoxvirus infections--200 years after Jenner's revolutionary immunization.控制正痘病毒感染——詹纳革命性免疫接种200年后
Arch Immunol Ther Exp (Warsz). 1996;44(5-6):373-8.
引用本文的文献
1
Mpox multiprotein virus-like nanoparticle vaccine induces neutralizing and protective antibodies in mice and non-human primates.猴痘多蛋白病毒样纳米颗粒疫苗在小鼠和非人灵长类动物中诱导产生中和抗体和保护性抗体。
Nat Commun. 2025 May 21;16(1):4726. doi: 10.1038/s41467-025-59826-8.
2
Orally available nucleoside analog UMM-766 provides protection in a murine model of orthopox disease.口服核苷类似物 UMM-766 可在正痘病毒病的小鼠模型中提供保护。
Microbiol Spectr. 2024 Apr 2;12(4):e0358623. doi: 10.1128/spectrum.03586-23. Epub 2024 Feb 23.
3
Evaluation of Virulence in Cynomolgus Macaques Using a Virus Preparation Enriched for the Extracellular Form of Monkeypox Virus.评估食蟹猴猴痘病毒的毒力：使用富含猴痘病毒细胞外形式的病毒制剂。
Viruses. 2022 Sep 9;14(9):1993. doi: 10.3390/v14091993.
4
Lipid nanoparticle delivery of unmodified mRNAs encoding multiple monoclonal antibodies targeting poxviruses in rabbits.脂质纳米颗粒在兔体内递送编码多种靶向痘病毒单克隆抗体的未修饰mRNA。
Mol Ther Nucleic Acids. 2022 May 10;28:847-858. doi: 10.1016/j.omtn.2022.05.025. eCollection 2022 Jun 14.
5
Immunology and Virus Diseases.免疫学与病毒疾病
J R Coll Physicians Lond. 1970 Oct;5(1):31-45.
6
Intranasal monkeypox marmoset model: Prophylactic antibody treatment provides benefit against severe monkeypox virus disease.鼻内接种猴痘绒猴模型：预防性抗体治疗可有效预防严重猴痘病毒病。
PLoS Negl Trop Dis. 2018 Jun 21;12(6):e0006581. doi: 10.1371/journal.pntd.0006581. eCollection 2018 Jun.
7
The strategic use of novel smallpox vaccines in the post-eradication world.在后天花消除世界中新型天花疫苗的战略应用。
Expert Rev Vaccines. 2011 Jul;10(7):1021-35. doi: 10.1586/erv.11.46.
8
Smallpox vaccines: targets of protective immunity.天花疫苗：保护性免疫的靶标。
Immunol Rev. 2011 Jan;239(1):8-26. doi: 10.1111/j.1600-065X.2010.00975.x.
9
Use of the Aerosol Rabbitpox Virus Model for Evaluation of Anti-Poxvirus Agents.使用气溶胶兔痘病毒模型评估抗痘病毒药物。
Viruses. 2010 Sep 27;2(9):2096-2107. doi: 10.3390/v2092096.
10
Characterization and use of mammalian-expressed vaccinia virus extracellular membrane proteins for quantification of the humoral immune response to smallpox vaccines.用于定量评估天花疫苗体液免疫反应的哺乳动物表达痘苗病毒细胞外膜蛋白的表征与应用
Clin Vaccine Immunol. 2007 Aug;14(8):1032-44. doi: 10.1128/CVI.00050-07. Epub 2007 Jun 27.
本文引用的文献
1
A note on the immunogenicity of ultra-violet irradiated vaccinia virus in man.关于紫外线照射的痘苗病毒在人体中的免疫原性的一则笔记。
J Hyg (Lond). 1962 Mar;60(1):79-83. doi: 10.1017/s0022172400039322.
2
Studies smallpox and complications of smallpox vaccination.研究天花及天花疫苗接种的并发症。
Pediatrics. 1960 Aug;26:176-89.
3
IMMUNOGENICITY OF ULTRAVIOLET-IRRADIATED, NON-INFECTIOUS, VACCINIA-VIRUS VACCINE IN INFANTS AND YOUNG CHILDREN.
Lancet. 1965 Mar 13;1(7385):573-4. doi: 10.1016/s0140-6736(65)91146-3.
4
Antibody production by hypogammaglobulinemic patients.低丙种球蛋白血症患者的抗体产生
J Immunol. 1962 Apr;88:443-9.
5
Dissociation of delayed-hypersensitivy and antibody-synthesising capacities in man. Report of two sibships with thymic dysplasia, lymphoid tissue depletion, and normal immunoglobulins.人类迟发型超敏反应与抗体合成能力的分离。两例伴有胸腺发育不良、淋巴组织耗竭及正常免疫球蛋白的同胞病例报告。
Lancet. 1966 Jul 2;2(7453):5-8. doi: 10.1016/s0140-6736(66)91742-9.
Zotero 插件